Day2, July 6, 12:30 p.m., Session B:
The bavarian therapeutic strategy to combat the COVID 19 pandemic
Dr. Stefan Löffler studied Biochemistry and Pharmaceutical Sciences and Technologies in Munich and Tübingen. Having finished his PhD in the wider field of biomedicine and pharmacology at the university of Bonn, he joined Explicat Pharma in 2021.
He fills the role of CMC-Projectmanager focusing on pharmaceutical development and process analytical technology.
Copyright © 2022 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten